28062126|t|Cross reactivity of immune responses to porcine reproductive and respiratory syndrome virus infection
28062126|a|Because porcine reproductive and respiratory syndrome virus (PRRSV) exhibits extensive genetic variation among field isolates, characterizing the extent of cross reactivity of immune responses, and most importantly cell-mediated immunity (CMI), could help in the development of broadly cross-protective vaccines. We infected 12 PRRSV -naïve pigs with PRRSV strain FL12 and determined the number of interferon (IFN)-γ secreting cells (SC) by ELISpot assay using ten type 2 and one type 1 PRRSV isolates as recall antigens. The number of IFN-γ SC was extremely variable among animals, and with exceptions, late to appear. Cross reactivity of IFN-γ SC among type 2 isolates was broad, and we found no evidence of an association between increased genetic distance among isolates and the intensity of the CMI response. Comparable to IFN-γ SC, total antibodies evaluated by indirect immunofluorescence assay (IFA) were cross reactive, however, neutralizing antibody titers could only be detected against the strain used for infection. Finally, we observed a moderate association between homologous IFN-γ SC and neutralizing antibodies.
28062126	0	16	Cross reactivity	T038	UMLS:C0872139
28062126	20	36	immune responses	T038	UMLS:C0301872
28062126	40	91	porcine reproductive and respiratory syndrome virus	T005	UMLS:C0376536
28062126	92	101	infection	T038	UMLS:C3714514
28062126	110	161	porcine reproductive and respiratory syndrome virus	T005	UMLS:C0376536
28062126	163	168	PRRSV	T005	UMLS:C0376536
28062126	219	227	isolates	T103	UMLS:C1764827
28062126	248	254	extent	T082	UMLS:C0439792
28062126	258	274	cross reactivity	T038	UMLS:C0872139
28062126	278	294	immune responses	T038	UMLS:C0301872
28062126	317	339	cell-mediated immunity	T038	UMLS:C3536823
28062126	341	344	CMI	T038	UMLS:C3536823
28062126	405	413	vaccines	T103	UMLS:C0042210
28062126	418	426	infected	T033	UMLS:C0439663
28062126	430	435	PRRSV	T005	UMLS:C0376536
28062126	443	447	pigs	T204	UMLS:C0039005
28062126	453	470	PRRSV strain FL12	T005	UMLS:C0376536
28062126	500	518	interferon (IFN)-γ	T103	UMLS:C0021745
28062126	519	534	secreting cells	T017	UMLS:C0007634
28062126	536	538	SC	T017	UMLS:C0007634
28062126	567	594	type 2 and one type 1 PRRSV	T005	UMLS:C0376536
28062126	595	603	isolates	T103	UMLS:C1764827
28062126	607	622	recall antigens	T033	UMLS:C1855779
28062126	638	643	IFN-γ	T103	UMLS:C0021745
28062126	644	646	SC	T017	UMLS:C0007634
28062126	676	683	animals	T204	UMLS:C0003062
28062126	722	738	Cross reactivity	T038	UMLS:C0872139
28062126	742	747	IFN-γ	T103	UMLS:C0021745
28062126	748	750	SC	T017	UMLS:C0007634
28062126	757	763	type 2	T005	UMLS:C0376536
28062126	764	772	isolates	T103	UMLS:C1764827
28062126	868	876	isolates	T103	UMLS:C1764827
28062126	902	914	CMI response	T038	UMLS:C3536823
28062126	930	935	IFN-γ	T103	UMLS:C0021745
28062126	936	938	SC	T017	UMLS:C0007634
28062126	946	956	antibodies	T103	UMLS:C0003241
28062126	970	1003	indirect immunofluorescence assay	T058	UMLS:C0282647
28062126	1005	1008	IFA	T058	UMLS:C0282647
28062126	1015	1029	cross reactive	T038	UMLS:C0010357
28062126	1040	1061	neutralizing antibody	T103	UMLS:C0475463
28062126	1083	1091	detected	T033	UMLS:C0442726
28062126	1120	1129	infection	T038	UMLS:C3714514
28062126	1194	1199	IFN-γ	T103	UMLS:C0021745
28062126	1200	1202	SC	T017	UMLS:C0007634
28062126	1207	1230	neutralizing antibodies	T103	UMLS:C0475463